medigraphic.com
ISSN 0016-3813 (Print)

2003, Number s1

<< Back Next >>

Gac Med Mex 2003; 139 (s1)

The Salvadorean Experience with Pharmacologic Interruption of Ectopic Pregnancy.

Hernández E, Espinoza H

Language: Spanish
References: 11
Page: 73-76
PDF size: 61.33 Kb.


ABSTRACT

Ectopic pregnancy is an important cause of maternal mortality during the first trimester. For some cases of ectopic pregnancy, pharmacologic treatment with methotrexate represents an alternative to surgical procedures. In this report, we present the results of treatment with methotrexate in 25 women with ectopic pregnancies treated at a hospital in San Salvador, El Salvador, between February 2001 and March 2002. Before offering this treatment, certain inclusion and intervention criteria were defined. A follow-up hysterosalpingography was performed in all women to evaluate the condition of fallopian tubes. Twenty two patients (88%) who received treatment with methotrexate were considered treatment successes, that is, no surgery was required; at follow-up, 82% of these successful cases were found to have permeable fallopian tubes. Surgical intervention was necessary in only three cases; tubal permeability was found in two of these cases (75%).


REFERENCES

  1. Tay JI, Moore J, Walker JJ. Ectopic pregnancy. Br Med J. 2000;320:916-919.

  2. Storeide O, Veholmen M, Eide M, Bergsjo P, Sandvei R. The incidence of ectopic pregnancy in Hordaland County, Norway 1976-1993. Acta Obstet Gynecol Scand 1997;76:345-349.

  3. Rajkhowa M, Glass MR, Rutherford AJ, Balen AH, Sharma V, Cuckle HS. Trends in the incidence of ectopic pregnancy in England and Wales from 1966 to 1996. Br J Obstet Gynecol 2000;107:369-374.

  4. Churgay CA, Apgar BS. Ectopic pregnancy: an update on technologic advances in diagnosis and treatment. Prim Care 1993;20:629-638.

  5. Luciano AA, Roy G, Solima E. Ectopic pregnancy from surgical emergency to medical management. Ann N Y Acad Sci 2001;943:235-254.

  6. Morlock RJ, Lafata JE, Eisenstein D. Cost-effectiveness of single-dose methotrexate compared with laparoscopic treatment of ectopic pregnancy. Obstet Gynecol 2000;95:407-412.

  7. Federación Internacional de Ginecología y Obstetricia. Manual de reproducción humana. New York: The Parthenon Publishing Group, Inc.;1994. pp.401-421.

  8. Thonneau P, Hijazi Y, Goyaux N, Calvez T, Keita N. Ectopic pregnancy in Conakry, Guinea. Bull World Health Org 2002;80:365-370.

  9. Liskin LS. Maternal morbidity in developing countries: a review and comments. Int J Gynaecol Obstet. 1992;37:77-87.

  10. ACOG practice bulletin. Medical management of tubal pregnancy. Number 3, December 1998. Clinical management guidelines for obstetrician-gynecologists. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1999;65:97-103.

  11. Hajenius PJ, Mol BWJ, Bossuyt PMM, Ankum WM, Van der Veen F. Intervenciones para el embarazo ectópico tubárico (Translated, Cochrane Review). En: The Cochrane Library, Issue 4, 2000, Oxford: UK;Updated software.




2020     |     www.medigraphic.com